Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to: Compare the effect of paracetamol alone against Paracetamol+Codeine association against the association of paracetamol + Cafeine in the treatment of post-traumatic acute pain of the limbs.


Clinical Trial Description

At admission to the emergency department, patients with acute post-traumatic pain will be included, regardless of their initial NRS .These patients will receive the necessary care for their injury (icing, reduction, immobilization, local care, sutures), then went home with a medical prescription and an outpatient appointment . At discharge and after obtaining their signed consent . All patients included will be randomized according to a numerical randomization table ( assigned in a 1:1:1 ratio) into 3 groups ( As a treatment for their post traumatic pain at discharge for 7 days ) : - Group 1: Paracetamol group who will receive paracetamol ( 1000 mg) : one pill 3 times a day for 7 days . - Group 2: Paracetamol-codeine group who will receive an association of 500 mg of Paracetamol and 30 mg of codeine : one pill twice a day for 7 days . - Group 3: Paracetamol-cafeine group who will receive an association of 500 mg of Paracetamol and 65 mg of cafeine : one pill 3 times a day for 7 days . For all patients included in the study, demographic and clinical data will be collected by the physician or investigator and recorded on a pre-established form. The demographic data recorded on each patient's chart were as follows: Age, sex, origin and personal pathological history: - Hypertension. - Diabetes. - Respiratory insufficiency. - Renal insufficiency. - Liver failure. - Allergy. And a Clinical examination data: - Pain intensity (NRS). - Mechanism of trauma and site of injury. - Other physical examination data: systolic blood pressure (SBP), heart rate (HR) and temperature. - Nature of traumatic injury. - Final diagnosis - Injury Severity Score (ISS). - NRS at discharge (at rest and on movement). Patients included will be assessed at Day 1 , Day 2 , Day 3 and Day 7 after discharge from the emergency department by a telephone call. This evaluation will include : - NRS at rest and during movement - Secondary use of another analgesic. - Patient satisfaction assessed by Likert scale, with 3 responses: - Satisfied - Moderately satisfied - Not satisfied - Side effects: epigastralgia, dizziness, somnolence, headache, nausea and/or vomiting, insomnia, constipation, palpitation, etc. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05229965
Study type Interventional
Source University of Monastir
Contact
Status Completed
Phase Phase 3
Start date November 1, 2022
Completion date June 27, 2023

See also
  Status Clinical Trial Phase
Completed NCT03247179 - The Mobile PTSD Coach App in Acute Injury Survivors N/A
Completed NCT04133623 - Ibuprofen Versus Ketorolac by Mouth in the Treatment of Acute Pain From Osteoarticular Trauma Phase 3
Completed NCT05630222 - Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen Phase 3
Recruiting NCT06351137 - Timecost of Intranasal Versus Intravenous Analgesia in Traumatic Pain N/A
Completed NCT03222518 - NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management Phase 3
Completed NCT03256903 - Methoxyflurane vs Standard Analgesic Treatment for Trauma Pain in Spanish Emergency Units Phase 3
Completed NCT03080350 - Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope Phase 4
Recruiting NCT06051227 - Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial Phase 3
Completed NCT04914988 - Continuous Fascia Iliaca Compartment Block in Geriatric Hip Fracture
Recruiting NCT03421275 - Intranasal Esketamine and Fentanyl for Pain in Minor Trauma Phase 4
Completed NCT03080324 - Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room Phase 4
Completed NCT01420159 - Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma Phase 3
Completed NCT03597945 - Magnesium-sulfate as Adjuvant in Prehospital Femoral Nerve Block for Patient With Diaphysial Femoral Fracture. N/A